Position in INCY
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$326,690
+$125,990 QoQ
Shares Held
3,471
+70.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026World Investment Advisors holds $5,395,760 across 16 Biotechnology names. INCY ranks #6 (6.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GERN |
Geron Corp
|
1,033,779 | $1,540,330 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,820 | $812,702 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
845 | $652,880 | |
| 4 | RPRX |
Royalty Pharma plc
|
9,949 | $477,253 | |
| 5 | MRNA |
Moderna, Inc.
|
6,999 | $355,549 | |
| 6 | INCY |
Incyte Corp
This page
|
3,471 | $326,690 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
4,978 | $321,728 | |
| 8 | DMAC |
DiaMedica Therapeutics Inc.
|
36,975 | $250,320 |
All Filings in INCY
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $326,690 | 3,471 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $200,700 | 2,032 | Shares | Sole | 2026-03-13 | |
| No filing history on record for this holder in this stock. | ||||||